PVL WATERTIGHT
Natural health product licensed in Canada
- Other names
- Mutant WATERTIGHT, Mutant WATERTIGHT +, North Coast Naturals WATERTIGHT, North Coast Naturals WATERTIGHT +, PVL WATERTIGHT +, WATERTIGHT, WATERTIGHT +
- Licence holder
- Fit Foods LP
- NPN or DIN-HM
- 80130846
- Status
- Active licence
- Licence date
- 25 April 2024
- Revision date
- 18 February 2026
- Form
- Capsule
- Route of administration
- Orale
- Application type
- Générale (non traditionelle)
If this product were sold in France
- Dose déclarée au-delà d'une limite
Vitamine B6: up to 100.02 mg a day according to the dosing instructions published by Health Canada (6 unités posologiques par jour au plus, pour les adultes), above the maximum dose of 2 mg set in France for a food supplement (2006 Order, not revised since November 2006).
arrêté du 9 mai 2006, annexe III. French orders of 9 May 2006 and 14 November 2006 as published in the Official Journal (maximum daily doses), retrieved 21 October 2026.
- Dose déclarée au-delà d'une limite
Potassium: up to 130.02 mg a day according to the dosing instructions published by Health Canada (6 unités posologiques par jour au plus, pour les adultes), above the maximum dose of 80 mg set in France for a food supplement (2006 Order, not revised since November 2006).
arrêté du 9 mai 2006, annexe III. French orders of 9 May 2006 and 14 November 2006 as published in the Official Journal (maximum daily doses), retrieved 21 October 2026.
- À vérifier
Vitamine B6: up to 100.02 mg a day according to the dosing instructions published by Health Canada, above the limite de sécurité from EFSAEuropean Food Safety Authority. for adults (12 mg a day). Le repère de l'EFSA porte sur l'apport total d'une journée, alimentation et compléments.
limite supérieure de sécurité (UL). EFSA, Overview on Tolerable Upper Intake Levels (version 11, August 2025), retrieved 21 October 2026.
- Conditions légales
Contains tea (Camellia sinensis). Green tea extracts must provide less than 800 mg of epigallocatechin-3-gallate per daily portion, with mandatory warnings.
annexe III, partie B (règlement (UE) 2022/2340). Regulation (EC) No 1925/2006, latest consolidated version, retrieved 21 October 2026.
- Conditions légales
Camellia sinensis (L.) Kuntze: Seules sont admises la poudre issue du broyage des feuilles et les préparations obtenues à partir des solvants suivants : l'eau, l'alcool à 25 % (v/v), ainsi que les solvants autorisés pour la décaféination ou la suppression des matières irritantes et amères. Les recommandations d'emploi ne doivent pas conduire à une ingestion quotidienne d'EGCG supérieure à 300 mg. L'étiquetage doit comporter des avertissements déconseillant leur prise en dehors des repas, ainsi que leur consommation par les enfants, les adolescents, les femmes enceintes ou allaitantes.
arrêté du 24 juin 2014, annexe I. French orders of 9 May 2006 (nutrients), 24 June 2014 (plants) and 26 September 2016 (other substances), consolidated LEGI collection, retrieved 23 October 2026.
- Conditions légales
Juniperus communis L.: L'étiquetage doit comporter un avertissement recommandant de ne pas utiliser en cas d'insuffisance rénale et un avertissement recommandant de ne pas utiliser de manière prolongée (maximum 6 semaines)
arrêté du 24 juin 2014, annexe I. French orders of 9 May 2006 (nutrients), 24 June 2014 (plants) and 26 September 2016 (other substances), consolidated LEGI collection, retrieved 23 October 2026.
A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.
Composition
| Medicinal ingredient and source | Per dosage unit, according to the source | Maximum per day, adult |
|---|---|---|
| Camellia sinensis Source : Camellia sinensis - feuille Potency : 75 % Catechins | Not specified | Not calculated |
| Taraxacum officinale Source : Taraxacum officinale - Racine Extract : Matériel brut sec Extraction ratio : 20:1 Dry plant equivalent : 3,333.4 mg | 166.67 mg | Not calculated |
| Juniperus communis Source : Juniperus communis - Fruit Extract : Matériel brut sec Extraction ratio : 4:1 Dry plant equivalent : 333.33 mg | 83.33 mg | Not calculated |
| Vitamine B6 Source : Chlorhydrate de pyridoxine | 16.67 mg | 100,020 µg |
| Calcium Source : Carbonate de calcium | 33.33 mg | 199,980 µg |
| Magnésium Source : Oxyde de magnésium | 24.67 mg | 148,020 µg |
| Potassium Source : Chlorure de potassium | 21.67 mg | 130,020 µg |
| Camellia sinensis Source : Camellia sinensis - feuille Potency : 6 % Caffeine | 41.67 mg | Not calculated |
| Camellia sinensis Source : Camellia sinensis - feuille Potency : 45 % Epigallocatechin 3-gallate | Not specified | Not calculated |
| Apium graveolens | 41.67 mg | Not calculated |
| Citrus limon Source : Citrus limon - Fruit | 20.83 mg | Not calculated |
| Vaccinium macrocarpon | 20.83 mg | Not calculated |
Non-medicinal ingredients
Cellulose microcristalline, Eau purifiée, Stéarate de magnésium, Dioxyde de silicium, Dextrose, Croscarmellose de sodium, Poudre d'enveloppes d'Oryza sativa (Riz), Silicate de calcium, Hypromellose, Acide stéarique
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Adultes | minimum: 19 years | 3 Capsule | 2 Tous les jours |
Uses authorised in Canada
Text supplied in English because no French text is available.
Source of/Provides antioxidants. Taraxacum officinale is traditionally used in Herbal Medicine as a diuretic.
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
No French warning text available in the imported data.
Warnings are available in English on the official record.
Source
Official Health Canada record, licence 80130846
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
List in the official revision dated (register: Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks).
Has the product changed? Photograph the packaging.